{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:55:54Z","timestamp":1778824554228,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH24EA2001"],"award-info":[{"award-number":["JPMH24EA2001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Fertility preservation for patients with cancer or other diseases who receive gonadotoxic treatment has gained importance as cancer survival rates increase. In Japan, a database for registering all fertility preservation patients, named the Japan Oncofertility Registry (JOFR), was established in 2018. This study aimed to analyze recent trends in fertility preservation in Japan utilizing data from the JOFR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data was extracted from the JOFR for patients who consulted fertility preservation teams until May 2024. A descriptive analysis was conducted to examine trends in patient demographics, cancer types, fertility preservation treatments, complications, and outcomes. The data covered the period from diagnosis to fertility preservation and subsequent usage or disposal of frozen specimens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 11,510 patients were recorded, with 9491 undergoing fertility preservation treatments. The number of patients increased steadily after 2006. After 2021, the number of female patients was much higher than the number of male patients. The most common primary diseases were breast cancer among women and testicular tumors and leukemia among men. There were some complications including ovarian hyperstimulation syndrome (5.0%), bleeding (0.12%), and infections (0.05%) for women. Seven hundred and sixty clinical pregnancies were recorded, with 440 using preserved specimens. The discard rate was 16.3% for men and 3.7% for women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The study highlights recent trends in the growing number of cases undergoing fertility preservation in Japan. It also identifies several issues to be solved in fertility preservation in Japan, regarding its efficacy and safety, as well as the medical provision system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10147-025-02725-1","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T03:13:18Z","timestamp":1740712398000},"page":"684-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends in fertility preservation treatments in Japan until 2023: analysis of the Japan Oncofertility Registry"],"prefix":"10.1007","volume":"30","author":[{"given":"Takao","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-5600","authenticated-orcid":false,"given":"Miyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Urata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youtaro","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Osuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"6","key":"2725_CR1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.23.01367","volume":"42","author":"THM Keegan","year":"2024","unstructured":"Keegan THM, Abrah\u00e3o R, Alvarez EM (2024) Survival trends among adolescents and young adults diagnosed with cancer in the United States: comparisons with children and older adults. J Clin Oncol 42(6):630\u2013641","journal-title":"J Clin Oncol"},{"issue":"19","key":"2725_CR2","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW, Mangu PB, Beck LN et al (2013) Fertility preseration for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500\u20132510","journal-title":"J Clin Oncol"},{"key":"2725_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40738-015-0004-3","volume":"1","author":"BL Bermas","year":"2015","unstructured":"Bermas BL, Sammaritano LR (2015) Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Fertil Res Pract 1:13","journal-title":"Fertil Res Pract"},{"issue":"1","key":"2725_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10147-018-1252-0","volume":"24","author":"M Harada","year":"2019","unstructured":"Harada M, Osuga Y (2019) Fertility preservation for female cancer patients. Int J Clin Oncol 24(1):28\u201333","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"2725_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/biolre\/ioac072","volume":"107","author":"KTD Tran","year":"2022","unstructured":"Tran KTD, Valli-Pulaski H, Colvin A et al (2022) Male fertility preservation and restoration strategies for patients undergoing gonadotoxic therapies\u2020. Biol Reprod 107(2):382\u2013405","journal-title":"Biol Reprod"},{"issue":"6","key":"2725_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/humupd\/dmn041","volume":"14","author":"R Beck-Fruchter","year":"2008","unstructured":"Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14(6):553\u2013561","journal-title":"Hum Reprod Update"},{"issue":"17","key":"2725_CR7","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","volume":"29","author":"B Gerber","year":"2011","unstructured":"Gerber B, von Minckwitz G, Stehle H et al (2011) Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 29(17):2334\u20132341","journal-title":"J Clin Oncol"},{"issue":"5","key":"2725_CR8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/humrep\/dev037","volume":"30","author":"N Hasky","year":"2015","unstructured":"Hasky N, Uri-Belapolsky S, Goldberg K et al (2015) Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma? Hum Reprod 30(5):1089\u20131101","journal-title":"Hum Reprod"},{"key":"2725_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101308","volume":"100","author":"K Duffin","year":"2024","unstructured":"Duffin K, Mitchell RT, Brougham MFH et al (2024) Impacts of cancer therapy on male fertility: past and present. Mol Aspects Med 100:101308","journal-title":"Mol Aspects Med"},{"issue":"6","key":"2725_CR10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/humrep\/dez043","volume":"34","author":"H Valli-Pulaski","year":"2019","unstructured":"Valli-Pulaski H, Peters KA, Gassei K et al (2019) Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers. Hum Reprod 34(6):966\u2013977","journal-title":"Hum Reprod"},{"issue":"1","key":"2725_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bju.14455","volume":"123","author":"JA Moody","year":"2019","unstructured":"Moody JA, Ahmed K, Yap T et al (2019) Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway. BJU Int 123(1):160\u2013172","journal-title":"BJU Int"},{"issue":"5","key":"2725_CR12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10815-019-01419-8","volume":"36","author":"G Shoham","year":"2019","unstructured":"Shoham G, Levy-Toledano R, Leong M et al (2019) Oncofertility: insights from IVF specialists\u2014a worldwide web-based survey analysis. J Assist Reprod Genet 36(5):1013\u20131021","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"2725_CR13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.fertnstert.2017.05.024","volume":"108","author":"F Martinez","year":"2017","unstructured":"Martinez F (2017) International Society for Fertility Preservation\u2013ESHRE\u2013ASRM Expert Working Group. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril 108(3):407\u2013415","journal-title":"Fertil Steril"},{"key":"2725_CR14","doi-asserted-by":"crossref","first-page":"1148314","DOI":"10.3389\/fendo.2023.1148314","volume":"14","author":"N Ozimek","year":"2023","unstructured":"Ozimek N, Salama M, Woodruff TK (2023) National oncofertility registries around the globe: a pilot survey. Front Endocrinol (Lausanne) 14:1148314","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"2725_CR15","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2217\/fon-2016-0187","volume":"12","author":"N Suzuki","year":"2016","unstructured":"Suzuki N (2016) Oncofertility in Japan: advances in research and the roles of oncofertility consortia. Future Oncol 12(20):2307\u20132311","journal-title":"Future Oncol"},{"issue":"12","key":"2725_CR16","first-page":"1246","volume":"50","author":"Y Takai","year":"2023","unstructured":"Takai Y (2023) Oncofertility care in Japan update-what we aim by public funding (in Japanese). Gan To Kagaku Ryoho 50(12):1246\u20131252","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"2725_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmb2.12256","volume":"18","author":"T Furui","year":"2018","unstructured":"Furui T, Takai Y, Kimura F et al (2018) Fertility preservation in adolescent and young adult cancer patients: from a part of a national survey on oncofertility in Japan. Reprod Med Biol 18(1):97\u2013104","journal-title":"Reprod Med Biol"},{"issue":"1","key":"2725_CR18","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.12581","volume":"23","author":"S Takae","year":"2024","unstructured":"Takae S, Harada M, Nakamura K et al (2024) Reproductive outcomes of embryo cryopreservation and transfer at the start-up phase of fertility preservation in Japan. Reprod Med Biol 23(1):e12581","journal-title":"Reprod Med Biol"},{"issue":"2","key":"2725_CR19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10147-020-01801-y","volume":"26","author":"S Okamoto","year":"2021","unstructured":"Okamoto S, Fujii N, Yoshioka N et al (2021) Nationwide survey of fertility preservation in patients with hematological malignancies in Japan. Int J Clin Oncol 26(2):438\u2013442","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2725_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10147-014-0676-4","volume":"20","author":"C Shimizu","year":"2015","unstructured":"Shimizu C, Kato T, Tamura N et al (2015) Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients. Int J Clin Oncol 20(1):82\u201389","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"2725_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12185-016-2134-8","volume":"105","author":"T Kobayashi","year":"2017","unstructured":"Kobayashi T, Shin T, Nishio K et al (2017) A questionnaire survey on attitude toward sperm cryopreservation among hematologists in Japan. Int J Hematol 105(3):349\u2013352","journal-title":"Int J Hematol"},{"issue":"4","key":"2725_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/jayao.2022.0110","volume":"12","author":"K Shigematsu","year":"2023","unstructured":"Shigematsu K, Shimizu C, Furui T et al (2023) Current status and issues of the Japan Oncofertility Registry. J Adolesc Young Adult Oncol 12(4):584\u2013591","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2725_CR23","unstructured":"Statistics Bureau, Ministry of Internal Affairs and Communications (2024) Population and population change rate by prefecture; Chapter 2 Population Households. https:\/\/www.stat.go.jp\/data\/nihon\/02.html. Accessed 28 July 2024"},{"issue":"18","key":"2725_CR24","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","volume":"24","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917\u20132931","journal-title":"J Clin Oncol"},{"issue":"2","key":"2725_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10147-021-02081-w","volume":"27","author":"M Harada","year":"2022","unstructured":"Harada M, Kimura F, Takai Y et al (2022) Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1. Int J Clin Oncol 27(2):265\u2013280","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"2725_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10147-021-02076-7","volume":"27","author":"A Tozawa","year":"2022","unstructured":"Tozawa A, Kimura F, Takai Y et al (2022) Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2. Int J Clin Oncol 27(2):281\u2013300","journal-title":"Int J Clin Oncol"},{"issue":"10","key":"2725_CR27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jog.14073","volume":"45","author":"Y Sanada","year":"2019","unstructured":"Sanada Y, Harada M, Kunitomi C et al (2019) A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. J Obstet Gynaecol Res 45(10):2021\u20132028","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2725_CR28","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.12453","volume":"21","author":"C Kunitomi","year":"2022","unstructured":"Kunitomi C, Harada M, Sanada Y et al (2022) The possible effects of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan. Reprod Med Biol 21(1):e12453","journal-title":"Reprod Med Biol"},{"issue":"1","key":"2725_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12282-023-01526-6","volume":"31","author":"M Miyashita","year":"2024","unstructured":"Miyashita M, Kumamaru H, Niikura N et al (2024) Annual report of the Japanese Breast Cancer Registry for 2019. Breast Cancer 31(1):16\u201323","journal-title":"Breast Cancer"},{"issue":"10","key":"2725_CR30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/jjco\/hyaa110","volume":"50","author":"K Kojo","year":"2020","unstructured":"Kojo K, Kawai K, Kawahara T et al (2020) Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012\u20132015 hospital-based cancer registry data. Jpn J Clin Oncol 50(10):1201\u20131208","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"2725_CR31","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13174","volume":"29","author":"M Ciccarone","year":"2020","unstructured":"Ciccarone M, Hohaus S, Pulsoni A et al (2020) Preliminary results of a counselling programme for fertility preservation in female cancer patients: the experience of the GEMME DORMIENTI network. Eur J Cancer Care (Engl) 29(1):e13174","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"4","key":"2725_CR32","first-page":"349","volume":"3","author":"K McCarter","year":"2022","unstructured":"McCarter K, Stewart J, Gordhandas S et al (2022) The use of fertility preservation services for cancer patients: a single institution experience. F S Rep 3(4):349\u2013354","journal-title":"F S Rep"},{"issue":"1","key":"2725_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.rbmo.2020.09.001","volume":"42","author":"K Kuroda","year":"2021","unstructured":"Kuroda K, Nagai S, Ikemoto Y et al (2021) Incidences and risk factors of moderate-to-severe ovarian hyperstimulation syndrome and severe hemoperitoneum in 1,435,108 oocyte retrievals. Reprod Biomed Online 42(1):125\u2013132","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"2725_CR34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humupd\/dmu035","volume":"20","author":"E Somigliana","year":"2014","unstructured":"Somigliana E, Peccatori FA, Filippi F et al (2014) Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation. Hum Reprod Update 20(6):944\u2013951","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2725_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10815-012-9909-5","volume":"30","author":"SN Babayev","year":"2013","unstructured":"Babayev SN, Arslan E, Kogan S et al (2013) Evaluation of ovarian and testicular tissue cryopreservation in children undergoing gonadotoxic therapies. J Assist Reprod Genet 30(1):3\u20139","journal-title":"J Assist Reprod Genet"},{"key":"2725_CR36","first-page":"117955811984586","volume":"13","author":"M Wolff","year":"2019","unstructured":"Wolff M, Andersen CY, Woodruff TK et al (2019) FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-preservation networks\u2014what can we learn from their experiences? Clin Med Insights Reprod Health 13:1179558119845865","journal-title":"Clin Med Insights Reprod Health"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02725-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T15:00:56Z","timestamp":1743260456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02725-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2725"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02725-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}